False resistance after artemether-lumefantrine treatment in a falciparum malaria patient in Turkey: A case report.
Artemisinin-based combination therapy
Malaria
P. falciparum
Journal
IDCases
ISSN: 2214-2509
Titre abrégé: IDCases
Pays: Netherlands
ID NLM: 101634540
Informations de publication
Date de publication:
2019
2019
Historique:
received:
11
06
2019
revised:
01
07
2019
accepted:
22
07
2019
entrez:
9
11
2019
pubmed:
9
11
2019
medline:
9
11
2019
Statut:
epublish
Résumé
Artemisinin-based combination therapy (ACT) is recommended by the World Health Organization as first-line treatment of uncomplicated Plasmodium falciparum malaria. ACT treatments failures among travellers returning from Africa to non-endemic countries are considered to be caused by resistance. We report on a case of artemether-lumefantrine treatment failure in a Turkish traveller with uncomplicated Information on returning travellers, includes ensuring that the patients receive supervised treatment with the recommended dose of a quality controlled medicine, routine follow-up of all cases, assessment of adequate absorption of the drug, and/or testing the prevalence of molecular markers of drug resistance if validated, can be an important source of an early warning system for emerging resistance.
Identifiants
pubmed: 31700799
doi: 10.1016/j.idcr.2019.e00607
pii: S2214-2509(19)30160-X
pii: e00607
pmc: PMC6831798
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e00607Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
© 2019 The Authors.
Déclaration de conflit d'intérêts
None of the authors report any conflicts of interest.
Références
Pathog Glob Health. 2013 Jan;107(1):30-4
pubmed: 23432861
Clin Infect Dis. 2017 Jan 15;64(2):199-206
pubmed: 27986683
Trop Med Parasitol. 1993 Jun;44(2):111-2
pubmed: 8367657
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28137810
PLoS One. 2017 Nov 28;12(11):e0188613
pubmed: 29182619
Clin Microbiol Infect. 2003 Jun;9(6):497-504
pubmed: 12848724
J Clin Microbiol. 2006 Mar;44(3):1087-9
pubmed: 16517900